| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |